CytoDyn (CYDY) Operating Leases (2019 - 2025)

CytoDyn (CYDY) posted Operating Leases of $34000.0 for Q1 2025, down 50.72% on a QoQ basis from $69000.0 in Q4 2024, and down 80.68% year-over-year from $176000.0 in Q1 2024.

CytoDyn (CYDY) Operating Leases (2019 - 2025) Analysis & Trends

CytoDyn's Operating Leases history runs 7 years deep, the most recent figure standing at $34000.0 for Q1 2025.

  • Quarterly Operating Leases fell 80.68% year-over-year to $34000.0 in Q1 2025, while the trailing twelve-month figure through Feb 2025 was $34000.0 (down 80.68% YoY) and the FY2024 annual result came in at $141000.0, down 50.18% from the prior year.
  • Operating Leases was $34000.0 for Q1 2025 at CytoDyn, down from $69000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $588000.0 in Q1 2021 and bottomed at $34000.0 in Q1 2025.
  • A 5-year average of $314352.9 and a median of $318000.0 in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2021 — Operating Leases jumped 776.19% — and 2025, when it plunged 80.68%.
  • CytoDyn's Operating Leases stood at $486000.0 in 2021, then declined by 27.37% to $353000.0 in 2022, then slumped by 40.23% to $211000.0 in 2023, then sank by 67.3% to $69000.0 in 2024, then sank by 50.72% to $34000.0 in 2025.
  • Business Quant data shows CYDY's Operating Leases at $34000.0 in Q1 2025, $69000.0 in Q4 2024, and $105000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 CytoDyn 267.79 Mn 267.79 Mn -

Historic Data

Download Data
DateValue
Feb 28, 2025 34,000.00
Nov 30, 2024 69,000.00
Aug 31, 2024 105,000.00
May 31, 2024 141,000.00
Feb 29, 2024 176,000.00
Nov 30, 2023 211,000.00
Aug 31, 2023 247,000.00
May 31, 2023 283,000.00
Feb 28, 2023 318,000.00
Nov 30, 2022 353,000.00
Aug 31, 2022 387,000.00
May 31, 2022 422,000.00
Feb 28, 2022 453,000.00
Nov 30, 2021 486,000.00
Aug 31, 2021 519,000.00
May 31, 2021 552,000.00
Feb 28, 2021 588,000.00
Nov 30, 2020 286,000.00
Aug 31, 2020 314,000.00
May 31, 2020 63,000.00